Tetra Biotech has been selected as a Daejeon-region company for the 2026 Startup-Centered University Program, led by Hannam University and run by Korea’s Ministry of SMEs and Startups (MSS) and the Korea Institute of Startup & Entrepreneurship Development (KISED).

One of the Korean government’s flagship startup initiatives, the program has regional lead universities identify promising early-stage startups and provide them with commercialization funding and tailored growth programs, linking university infrastructure with regional innovation resources to strengthen local startup ecosystems.

The selection is an independent endorsement of our technology and growth potential.

During the evaluation, Tetra Biotech presented its commercialization plan for TetraZyme™, an enzyme enhanced through Structure-Guided Mutation Engineering (SGME), 

along with the PCR master mixes and molecular diagnostic kits built on it.

Evaluators particularly highlighted our ability to develop and manufacture everything from the core enzyme technology to finished products, as well as our global market strategy.

With this support, we will accelerate further enhancement of our SGME enzymes, the development of new detection kits, the build-out of our quality and certification systems, and the expansion of our overseas sales channels. 

We will also work closely with Hannam University, the lead institution, to deliver tangible commercial results.